Kerala Ayurveda Limited (BOM:530163)
274.65
-7.10 (-2.52%)
At close: Jan 21, 2026
Kerala Ayurveda Revenue
Kerala Ayurveda had revenue of 348.39M INR in the quarter ending September 30, 2025, with 14.55% growth. This brings the company's revenue in the last twelve months to 1.26B, up 7.11% year-over-year. In the fiscal year ending March 31, 2025, Kerala Ayurveda had annual revenue of 1.20B with 16.32% growth.
Revenue (ttm)
1.26B
Revenue Growth
+7.11%
P/S Ratio
2.70
Revenue / Employee
3.42M
Employees
367
Market Cap
3.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.20B | 168.35M | 16.32% |
| Mar 31, 2024 | 1.03B | 95.06M | 10.15% |
| Mar 31, 2023 | 936.23M | 131.79M | 16.38% |
| Mar 31, 2022 | 804.44M | 183.70M | 29.59% |
| Mar 31, 2021 | 620.74M | -146.99M | -19.15% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sudarshan Pharma Industries | 5.92B |
| ZIM Laboratories | 3.66B |
| Albert David | 3.16B |
| Amanta Healthcare | 2.76B |
| Everest Organics | 1.89B |
| Medico Remedies | 1.72B |
| Medicamen Biotech | 1.70B |
| Jenburkt Pharmaceuticals | 1.59B |